Antidiabetic effects of the Platelet Rich Plasma (PRP): A Review

Authors

  • Wienaldi Department of Public Health, Fakultas Kedokteran Universitas Prima Indonesia Medan
  • Nyoman Ehrich Lister I Department of Biochemistry and Molecular Biology, Fakultas Kedokteran Universitas Prima Indonesia Medan

DOI:

https://doi.org/10.26452/ijrps.v13i3.1913

Abstract

Diabetes Mellitus (DM) is a metabolic illness that manifests as elevated blood glucose levels (hyperglycemia) as a result of kidney failure, particularly in insulin-producing cells. Platelet Rich Plasma is one of the treatments for hyperglycemia that takes a cutting-edge approach to cell regeneration and has attracted substantial attention in recent years (PRP). PRP can accelerate cell proliferation due to the large number of bioactive molecules found in PRP, the majority of which are platelet-derived growth factor (PDGF) protein, transforming growth factor (TGF-), vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), insulin-like growth factor (IGF), and fibroblast growth factor (FGF). This paper does a literature search or conducts a review of published research articles. Search for publications using the keywords PRP and DM or blood sugar levels in Google Scholar and Pubmed. The time period covered by the criterion for papers published in the recent five years is from 2017 to 2021. According to the literature search, there was three research examining the effect of PRP on blood sugar levels in the diabetic model, all of which used experimental animals. According to the literature review, PRP is a viable alternative in the treatment of diabetes mellitus that has a reasonably efficient effect on decreasing blood glucose levels.

Keywords:

PRP, DM, Antidiabetic

Downloads

Download data is not yet available.

References

P Auliya, F Oenzil, and Z D Dia Rofinda. Overview of Blood Sugar Levels in Andalas University Medical Faculty Students Who Have Overweight and Obesity. Jurnal Kesehatan Andalas, 5(3):528–533, 2016.

WHO. Global Report on Diabetes. World Health Organization, pages 88–88, 2016. ISBN 9789241565257.

F W Pagliuca, J R Millman, M Gürtler, M Segel, A Van Dervort, J H Ryu, Q P Peterson, D Greiner, and D A Melton. Generation of functional human pancreatic β cells in vitro. Cell, 159(2):428–439, 2014.

B Okere, L Lucaccioni, M Dominici, and L Iughetti. Cell therapies for pancreatic betacell replenishment. Italian Journal of Pediatrics, 42(1):62, 2016.

F W Pagliuca and D A Melton. How to make a functional β-cell. Development, 140(12):2472– 2483, 2013.

R Mani, S Mahantesha, T K Nandini, and R Lavanya. Growth Factors in Periodontal Regeneration. Journal of Advanced Oral Research, 5(2):1–5, 2014.

M Zhang, Q Lin, T Qi, T Wang, C. C Chen, A D Riggs, and D Zeng. Growth factors and medium hyperglycemia induce Sox9+ ductal cell differentiation into β cells in mice with reversal of diabetes. Proceedings of the National Academy of Sciences of the United States of America, 113(3):650–655, 2016.

A Dubey, R Chaudhary, A Bhatnagar, and A Sonker. Platelet growth factors from allogeneic platelet-rich plasma for clinical improvement in the split-thickness skin graft. Asian Journal of Transfusion Science, 9(2):155– 155, 2015.

C Cavallo, A Roffi, B Grigolo, E Mariani, L Pratelli, G Merli, E Kon, M Marcacci, and G Filardo. Platelet-Rich Plasma: The Choice of Activation Method Affects the Release of Bioactive Molecules. BioMed Research International, pages 1–7, 2016.

N N Knezevic, K D Candido, R Desai, and A D Kaye. Is Platelet-Rich Plasma a Future Therapy in Pain Management? Medical Clinics of North America, 100(1):199–217, 2016.

V Pavlovic, M Ciric, V Jovanovic, and P Stojanovic. Platelet Rich Plasma: a short overview of certain bioactive components. Open Medicine, 11(1):242–247, 2016.

O Martín-Solé, J Rodó, L García-Aparicio, J Blanch, V Cusí, and A Albert. Effects of Platelet-Rich Plasma (PRP) on a Model of Renal Ischemia-Reperfusion in Rats. PloS One, 11(8):e0160703, 2016.

N Salem, N Helmi, and N Assaf. Renoprotective Effect of Platelet-Rich Plasma on Cisplatin Induced Nephrotoxicity in Rats. Oxidative Medicine and Cellular Longevity, page 9658230, 2018.

N F El Tahawy, R A Rifaai, E A Saber, S R Saied, and R A Ibrahim. Effect of Platelet Rich Plasma (PRP) Injection on the Endocrine Pancreas of the Experimentally Induced Diabetes in Male Albino Rats: A Histological and

Immunohistochemical Study. Journal of Diabetes & Metabolism, 8(3), 2017.

R Dhurat and M Sukesh. Principles and methods of preparation of platelet-rich plasma: A review and author′s perspective. Journal of Cutaneous and Aesthetic Surgery, 7(4):189, 2014.

M Zarin, N Karbalaei, S Keshtgar, and M Nemati. Platelet-rich plasma improves impaired glucose hemostasis, disrupted insulin secretion, and pancreatic oxidative stress in streptozotocin-induced diabetic rat. Growth Factors, 37(5-6):226–237, 2019.

M Nemati, N Karbalaei, P Mokarram, and F Dehghani. Effects of platelet-rich plasma on the pancreatic islet survival and function, islet transplantation outcome and pancreatic pdx1 and insulin gene expression in streptozotocin induced diabetic rats. Growth Factors, 38(3- 4):137–151, 2020.

C Zheng, Q Zhu, X Liu, X Huang, C He, L Jiang, D Quan, X Zhou, and Z Zhu. Effect of plateletrich plasma (PRP) concentration on proliferation, neurotrophic function and migration of Schwann cells in vitro. Journal of Tissue Engineering and Regenerative Medicine, 10(5):428– 436, 2016.

R A Rifaai, N F El-Tahawy, and E Saber. Effect of Quercetin on the Endocrine Pancreas of the Experimentally Induced Diabetes in Male Albino Rats: A Histological and Immunohistochemical Study. Journal of Diabetes & Metabolism, 3(3), 2012.

H A Keenan, J K Sun, J Levine, A Doria, L P Aiello, G Eisenbarth, S Bonner-Weir, and G L King. Residual insulin production and pancreatic ß-cell turnover after 50 years of diabetes: Joslin Medalist Study. Diabetes, 59(11):2846– 2853, 2010.

A L Márquez-Aguirre, A A Canales-Aguirre, E Padilla-Camberos, H Esquivel-Solis, and N E Díaz-Martínez. Development of the endocrine pancreas and novel strategies for β-cell mass restoration and diabetes therapy. Brazilian Journal of Medical and Biological Research = Revista Brasileira de Pesquisas Medicas e Biologicas, 48(9):765–776, 2015.

Published

2022-08-01

How to Cite

Wienaldi, & Nyoman Ehrich Lister I. (2022). Antidiabetic effects of the Platelet Rich Plasma (PRP): A Review. International Journal of Research in Pharmaceutical Sciences, 13(3), 292–296. https://doi.org/10.26452/ijrps.v13i3.1913

Issue

Section

Review Article